A. A. P. M. V. D. Riet

The costs of peripheral blood progenitor cell reinfusion mobilised by granulocyte colony-stimulating factor following high dose melphalan as compared with conventional therapy in multiple myeloma.

G. Ossenkoppele, F. Rutten, C. U. Uyl‐de Groot, 1994, European journal of cancer.